National Institutes of Health - National Cancer Institute
Neuro-Oncology Branch
10 Center Drive, Bethesda, Maryland, 20892, United States
Additional Information:
This program meets 6/7 of the Guiding Principles for CNS Tumor Treatment Programs.
Institution part of the Center for Cancer Research.
Data for this program collected in 2023.
Accreditations:
- National Cancer Institute Designation: No
- Nurse Magnet Status: Yes
- Academic Affiliation: John Hopkins School of Medicine
Number of Full-Time Physicians:
Number of full-time physicians in this treatment program who dedicate at least 40% of their clinical practice to the treatment of adult patients diagnosed with brain and/or spine tumors:- 5 Neuro-oncologists or Medical Oncologists specializing in brain/spine tumors
- 4 Brain Neurosurgeons
- 4 Spine Neurosurgeons
- 5 Radiation Oncologists
- 4 Neuropathologists
Number of Adult Patients Treated for Brain and/or Spine Tumors Annually:
- [no data] Primary tumor patients
- [no data] Metastatic (Secondary) tumor patients
Number of Adult Patients Treated with Surgery Annually:
- 51 Primary brain tumor patients
- 11 Metastatic (Secondary) brain tumor patients
- 7 Primary spine tumor patients
- 4 Metastatic (Secondary) spine tumor patients
- 19 Skull base tumor patients
Specialized Treatments and Technologies Available:
Identifies whether the following treatment options are offered either at this institution or at an affiliated center.Available:
Drug:
- Immunotherapy
- Targeted therapy
Imaging Treatments and Technologies:
- MRI Spectroscopy
- MRI Tractography
- Perfusion MRI
Other:
Radiation Treatments and Technologies:
- 3D Conformal Radiation Therapy (3D-CRT)
- Intensity Modulated Radiation Therapy (IMRT)
- Stereotactic Radiosurgery
Surgical Treatments and Technologies:
- Awake Craniotomy
- Brain Mapping
- Endoscopic Surgery
- Fluorescence-guided surgery
- Intraoperative MRI
- Minimally Invasive Surgery
Clinical Trials:
Investigational treatments (or other interventions) available for the categories below:- Low Grade Glioma
- Meningioma
- Newly Diagnosed Glioblastoma
- Other Malignant Glioma
- Recurrent Glioblastoma
Other:
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Choroid Plexus Tumors
- Ependymoma
- Gliomatosis Cerebri
- Gliosarcoma or Primary CNS Sarcoma
- Histone Mutated Glioma
- Medulloblastoma
- Meningioma (High Grade)
- Parenchymal Pineal Region Tumors
- Pleomorphic Xanthoastrocytoma (PXA) and Anaplastic Pleomorphic Xanthoastrocytoma (APXA)
- tumors formerly known as Primitive Neuro-Ectodermal Tumors (PNET), including Embryonal Tumor with Multilayered Rosettes, Medulloepithelioma, CNS Neuroblastoma, CNS Ganglioneuroblastoma, CNS Embryonal Tumor NOS
- tumor entities emerging from methylation profiling of CNS-PNETs: CNS neuroblastoma with FOXR2 activation, CNS Ewing sarcoma family tumor with CIC alteration, CNS high-grade neuroepithelial tumor with MN1 alterations
- CNS high-grade neuroepithelial tumor with BCOR alteration
- IDH-mutated gliomas
Support Services Available:
Identifies whether the following clinical and non-clinical support services are offered either at this institution or at an affiliated center.Available:
- Advanced practice registered nurse
- Brain tumor board
- Brain tumor support group
- Caregiver support services
- Certified neuro registered nurse
- Discounted lodging
- Fellowship-trained neuro-oncologist
- Financial aid services
- Inpatient rehabilitation
- Molecular testing
- Neurological Intensive Care Unit (Neuro ICU)
- Neuropsychology services for CNS tumor patients
- Outpatient Rehabilitation
- Palliative care
- Survivorship services
- Transportation services
- Virtual second opinion service
Other:
- NCI-CONNECT Clinic
- Support for travel expenses and food
Last updated November 1, 2023
